134848-89-8

Basic information

• Product Name: (8S,11S,12R)-11-(cyclohexylmethyl)-8-<ethoxy>carbonyl>-L-phenylalanyl>amino>-12-hydroxy-5,9,13-trioxo-1-oxa-4,10-diazacyclotridecane
• Synonyms: (8S,11S,12R)-11-(cyclohexylmethyl)-8-<ethoxy>carbonyl>-L-phenylalanyl>amino>-12-hydroxy-5,9,13-trioxo-1-oxa-4,10-diazacyclotridecane
• CAS NO: 134848-89-8
• Molecular Weight: 673.807
• Mol File: 134848-89-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (8S,11S,12R)-11-(cyclohexylmethyl)-8-<ethoxy>carbonyl>-L-phenylalanyl>amino>-12-hydroxy-5,9,13-trioxo-1-oxa-4,10-diazacyclotridecane(CAS DataBase Reference)
• NIST Chemistry Reference: (8S,11S,12R)-11-(cyclohexylmethyl)-8-<ethoxy>carbonyl>-L-phenylalanyl>amino>-12-hydroxy-5,9,13-trioxo-1-oxa-4,10-diazacyclotridecane(134848-89-8)
• EPA Substance Registry System: (8S,11S,12R)-11-(cyclohexylmethyl)-8-<ethoxy>carbonyl>-L-phenylalanyl>amino>-12-hydroxy-5,9,13-trioxo-1-oxa-4,10-diazacyclotridecane(134848-89-8)

Safety Data

• Hazardous Substances Data: 134848-89-8(Hazardous Substances Data)

Upstream product

• 134848-73-0 (4S,5R)-4-Cyclohexylmethyl-2,2-dimethyl-oxazolidine-3,5-dicarboxylic acid 5-[2-((S)-4-benzyloxycarbonylamino-4-tert-butoxycarbonyl-butyrylamino)-ethyl] ester 3-tert-butyl ester 
• 134848-74-1 (8S,11S,12R)-11-(cyclohexylmethyl)-12-hydroxy-8-<<(phenylmethoxy)carbonyl>amino>-5,9,13-trioxo-1-oxa-4,10-diazacyclotridecane 
• 134848-72-9 Z-Glu(2-hydroxyethyl)-OtBu 
• 121533-54-8 (4S,5R)-3-tert-Butoxycarbonyl-4-cyclohexyl-methyl-2,2-dimethyloxazolidine-5-carboxylic acid 
• 34897-61-5 N-(benzyloxycarbonyl)-L-glutamic acid α-t-butyl ester dicyclohexylamine salt 
• 134849-00-6 (S)-2-[2-(2,2-Dimethyl-propionylamino)-ethoxycarbonylamino]-3-phenyl-propionic acid 

Relevant articles and documents

Design and synthesis of P2-P1'-linked macrocyclic human renin inhibitors

Using a computer model of the active site of human renin developed at Merck, we designed a series of novel P2-P1'-linked, macrocyclic renin inhibitors 3-10. These unique inhibitors incorporate a transition-state isostere within a 13- or 14-membered ring. The three most active compounds in this family were 13-membered-ring glutamine-derived inhibitor 3, 14-membered-ring diaminopropionic acid derived inhibitor 6, and 13-membered-ring diol 9 (IC50 0.61, 0.59, 0.65 μM, respectively). Modification of inhibitor 3 at P4 led to 56 nM macrocyclic renin inhibitor 39. This study shows the viability of renin inhibitor designs which incorporate a scissile-bond replacement within a macrocycle.